Australian Ethical has wasted no time putting its new head of equities, Nathan Parkin, to work.
Since joining the $13 billion money manager and superannuation fund in July, the industry veteran has been reshaping the firm’s portfolio by topping up on ASX blue chips, most notably blood plasma giant CSL, which he says finally looks attractive after years of being too expensive.
Loading…
